Distinguished in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

Luigi Strambi-Ferini

Milan, IT 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
Milan, IT 
OverviewLocationsClinical Research

Overview

Luigi Strambi-Ferini practices in Milan, Italy. Mr. Strambi-Ferini is rated as a Distinguished expert by MediFind in the treatment of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE). His top areas of expertise are Restless Legs Syndrome, REM Behavior Disorder, Insomnia, Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), and Tissue Biopsy.

His clinical research consists of co-authoring 298 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE).

Gender
Male

Locations

Milan, Italy
Other Locations
San Raffaele, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Proof of Concept, Multicentre, Phase 2, Double-Blind, Randomized, Placebo-Controlled Study on the Efficacy, Safety and Tolerability of d-Methadone in Moderate to Very Severe Restless Legs Syndrome With Periodic Limb Movements: the Glu-REST Study
A Proof of Concept, Multicentre, Phase 2, Double-Blind, Randomized, Placebo-Controlled Study on the Efficacy, Safety and Tolerability of d-Methadone in Moderate to Very Severe Restless Legs Syndrome With Periodic Limb Movements: the Glu-REST Study
Enrollment Status: Recruiting
Publish Date: September 04, 2024
Intervention Type: Drug, Other
Study Drug: D-methadone
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trial

298 Total Publications

Post-traumatic stress disorder and REM-sleep behavior disorder: exploring genetic associations and causal links.
Post-traumatic stress disorder and REM-sleep behavior disorder: exploring genetic associations and causal links.
Journal: medRxiv : the preprint server for health sciences
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Strambi-Ferini's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 7 Advanced Conditions
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile